These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22050485)

  • 1. Azithromycin in periodontal treatment: more than an antibiotic.
    Hirsch R; Deng H; Laohachai MN
    J Periodontal Res; 2012 Apr; 47(2):137-48. PubMed ID: 22050485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal healing and bone regeneration in response to azithromycin.
    Hirsch R
    Aust Dent J; 2010 Jun; 55(2):193-9. PubMed ID: 20604763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases.
    Blandizzi C; Malizia T; Lupetti A; Pesce D; Gabriele M; Giuca MR; Campa M; Del Tacca M; Senesi S
    J Periodontol; 1999 Sep; 70(9):960-6. PubMed ID: 10505797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic therapy in asthma exacerbation and in cystic fibrosis in children].
    Breborowicz A
    Pol Merkur Lekarski; 2011 May; 30(179):349-51. PubMed ID: 21675140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug concentration in inflamed periodontal tissues after systemically administered azithromycin.
    Gomi K; Yashima A; Iino F; Kanazashi M; Nagano T; Shibukawa N; Ohshima T; Maeda N; Arai T
    J Periodontol; 2007 May; 78(5):918-23. PubMed ID: 17470027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin.
    Higgins TJ
    Aust Dent J; 2010 Dec; 55(4):479; author reply 479-81. PubMed ID: 21133950
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic management of periodontal diseases using systemically administered agents.
    Mariotti A; Monroe PJ
    Dent Clin North Am; 1998 Apr; 42(2):245-62. PubMed ID: 9597336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of metronidazole vs. azithromycin for treatment of cyclosporine-induced gingival overgrowth.
    Chand DH; Quattrocchi J; Poe SA; Terezhalmy GT; Strife CF; Cunningham RJ
    Pediatr Transplant; 2004 Feb; 8(1):60-4. PubMed ID: 15009842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin: a new concept in adjuvant treatment of periodontitis.
    Muniz FW; de Oliveira CC; de Sousa Carvalho R; Moreira MM; de Moraes ME; Martins RS
    Eur J Pharmacol; 2013 Apr; 705(1-3):135-9. PubMed ID: 23499686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin: mechanisms of action and their relevance for clinical applications.
    Parnham MJ; Erakovic Haber V; Giamarellos-Bourboulis EJ; Perletti G; Verleden GM; Vos R
    Pharmacol Ther; 2014 Aug; 143(2):225-45. PubMed ID: 24631273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The evaluation of the clinical efficacy and tolerance of azithromycin in odontostomatological infections].
    Varvara G; D'Arcangelo C
    Minerva Stomatol; 1998; 47(1-2):57-62. PubMed ID: 9578649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis.
    Mencarelli A; Distrutti E; Renga B; Cipriani S; Palladino G; Booth C; Tudor G; Guse JH; Hahn U; Burnet M; Fiorucci S
    Eur J Pharmacol; 2011 Aug; 665(1-3):29-39. PubMed ID: 21554873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of polyphenols in periodontal inflammation.
    Palaska I; Papathanasiou E; Theoharides TC
    Eur J Pharmacol; 2013 Nov; 720(1-3):77-83. PubMed ID: 24184667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial.
    Haas AN; de Castro GD; Moreno T; Susin C; Albandar JM; Oppermann RV; Rösing CK
    J Clin Periodontol; 2008 Aug; 35(8):696-704. PubMed ID: 18631245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Azithromycin and bronchopulmonary infections].
    Leophonte P
    Pathol Biol (Paris); 1995 Jun; 43(6):534-41. PubMed ID: 8539078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Trial of metronidazole vs. azithromycin for treatment of cyclosporine-induced gingival overgrowth.
    Verma A; Dhawan A
    Pediatr Transplant; 2005 Feb; 9(1):132. PubMed ID: 15667627
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between piroxicam and azithromycin during distribution to human periodontal tissues.
    Malizia T; Batoni G; Ghelardi E; Baschiera F; Graziani F; Blandizzi C; Gabriele M; Campa M; Del Tacca M; Senesi S
    J Periodontol; 2001 Sep; 72(9):1151-6. PubMed ID: 11577945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.
    Fecik RA; Nguyen PL; Venkatraman L
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):741-7. PubMed ID: 16312149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.